Any nocebo effect that is even vaguely credible is a short term thing like this. It's criminal that phenomena like these have been conflated with the symptoms of people who are sick and suffering long term.Those examples are short term immediate reactions to an unexpected and discomforting situation. Some people faint at the sight of blood. That doesn't have anything to do with chronic or serious illness.
Recycling the 'asthma is psychosomatic' trope from the fin-de-sicle era are we? Proust's father would be proud.It's literally an ad, she's promoting her own book. What is this even?
This is plain laughable, it's like any random fake Facebook story, or some of the weird stuff you can find in the conspiracy fantasy communities.
So are those examples. One of is from the late 90s, the other from 60s. They are terrible examples. Medicine has been desperately trying to prove this stuff for well over a century and hasn't come up with anything.
This is horseshoe theory in action. It's similar to any random stuff from QAnon communities.
It's literally an ad, she's promoting her own book. What is this even?
This is plain laughable, it's like any random fake Facebook story, or some of the weird stuff you can find in the conspiracy fantasy communities.
So are those examples. One of is from the late 90s, the other from 60s. They are terrible examples. Medicine has been desperately trying to prove this stuff for well over a century and hasn't come up with anything.
This is horseshoe theory in action. It's similar to any random stuff from QAnon communities.
I was scrolling through my library's ebooks and that one already has a waiting list until the end of October.The hardback edition of Helen Pilcher's book 'This book may cause side effects. Why our minds are making us sick' was published this week (07/05/2026) - it's also available as Audiobook and on Kindle.
So the Guardian article IS pure book promotion
So we can look forward to even more promotions, Press and Radio interviews etc when the paperback edition is published. The name Helen Pilcher is familiar to me from some years ago, but I can't quite remember where I know her name from.
.
It’s a bit bleak how well these books seem to sell. I guess it’s a very enticing simple narrative.I was scrolling through my library's ebooks and that one already has a waiting list until the end of October.
I guess the one potential light to hold onto is my own (untested but I bet I'm not wrong) guess that not many people ever actually read these beyond enough to get a taste of 'what type of thing is this', effectively giving it a chance.It’s a bit bleak how well these books seem to sell. I guess it’s a very enticing simple narrative.
is that public library and they wait because there are x licenses? I admit to being quite out of touch with libraries, I'm imagining different books in different sections then get certain lending terms depending on popularity etc?I was scrolling through my library's ebooks and that one already has a waiting list until the end of October.
Yes, a public library. I don't know how many copies they have. I also noticed that some libraries estimate that each person would borrow a book for 2 weeks while some count 3 weeks per person (which is the max; you can extend it if no one is waiting for the book or get back in the queue if you haven't finished it). I can't see how many people are waiting because that particular app doesn't provide that info.is that public library and they wait because there are x licenses? I admit to being quite out of touch with libraries, I'm imagining different books in different sections then get certain lending terms depending on popularity etc?
The thing isReview on placebo injections on Knee Osteoarthritis -- not sure whether it warrants an own thread. Thought Edzards' Ernst blog article including others' comments could be interesting;
Previtali D, Merli G, Di Laura Frattura G, Candrian C, Zaffagnini S, Filardo G. The Long-Lasting Effects of "Placebo Injections" in Knee Osteoarthritis: A Meta-Analysis. Cartilage. 2021 Dec;13(1_suppl):185S-196S. doi: 10.1177/1947603520906597. Epub 2020 Mar 18. PMID: 32186401; PMCID: PMC8808779.
Free PMC full text:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808779/
Abstract
Objectives
To quantify the placebo effect of intraarticular injections for knee osteoarthritis in terms of pain, function, and objective outcomes. Factors influencing placebo effect were investigated.
Design
Meta-analysis of randomized controlled trials; Level of evidence, 2. PubMed, Web of Science, Cochrane Library, and grey literature databases were searched on January 8, 2020, using the string: (knee) AND (osteoarthritis OR OA) AND (injections OR intra-articular) AND (saline OR placebo). The following inclusion criteria were used: double-blind, randomized controlled trials on knee osteoarthritis, including a placebo arm on saline injections. The primary outcome was pain variation. Risk of bias was assessed using the RoB 2.0 tool, and quality of evidence was graded following the GRADE (Grading of Recommendations Assessment, Development and Evaluation) guidelines.
Results
Out of 2,363 records, 50 articles on 4,076 patients were included. The meta-analysis showed significant improvements up to the 6-month follow-up: Visual Analogue Scale (VAS)-pain −13.4 mean difference (MD) (95% confidence interval [CI]: −21.7/−5.1; P < 0.001), Western Ontario and McMaster Osteoarthritis Index (WOMAC)-pain −3.3 MD (95% CI: −3.9/−2.7; P < 0.001). Other significant improvements were WOMAC-stiffness −1.1 MD (95% CI: −1.6/−0.6; P < 0.001), WOMAC-function −10.1 MD (95% CI: −12.2/−8.0; P < 0.001), and Evaluator Global Assessment −21.4 MD (95% CI: −29.2/−13.6; P < 0.001). The responder rate was 52% (95% CI: 40% to 63%). Improvements were greater than the “minimal clinically important difference” for all outcomes (except 6-month VAS-pain). The level of evidence was moderate for almost all outcomes.
Conclusions
The placebo effect of knee injections is significant, with functional improvements lasting even longer than those reported for pain perception. The high, long-lasting, and heterogeneous effects on the scales commonly used in clinical trials further highlight that the impact of placebo should not be overlooked in the research on and management of knee osteoarthritis.
Edzard Ernst's take on the authors' conclusion:
https://edzardernst.com/2022/08/effects-of-placebo-injections-in-knee-osteoarthritis/
Mind that one of the commenters on Ernst's blog who seems to make some reasonable points might have her own blind spots with regard to what seems to be her hobbyhorse -- developing a hypothesis and offering a treatment of "non-malignant chronic pain without sufficient explanatory pathology".
It's fair to stress though that I don't think she uses her comments to promote her treatment or even just her ideas about that.
They are selling the most desired of all things by humans - the power of mind over matter, the ability to make ourselves and the world around us in our own mind's image.It’s a bit bleak how well these books seem to sell. I guess it’s a very enticing simple narrative.
They are selling the most desired of all things by humans - the power of mind over matter, the ability to make ourselves and the world around us in our own mind's image.
It is the greatest and cruelest snake oil act of them all.